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Objective: The aim of this study was to evaluate whether great saphenous vein (GSV) surgery without high ligation of the
saphenofemoral junction (SFJ) is beneﬁcial in terms of varicose vein recurrence.
Methods: This was a prospective randomized trial set in a private practice. From December 2000 to May 2004,
120 patients were enrolled. Patients were randomly allocated preoperatively to two groups undergoing GSV surgery with
(group A, n [ 60) or without (group B, n [ 60) high ligation of the SFJ. In four patients (two in each group), both
limbs were operated on. Inclusion criteria were primary varicose veins with SFJ incompetence resulting in GSV reﬂux.
Exclusion criteria were age <18 years, inability to give informed consent, associated small saphenous vein incompetence,
and prior GSV surgery. Mean follow-up was 8 years and was complete in all but one patient (99.2%). The primary end
point was varicose vein recurrence, deﬁned as treated lower limbs with new thigh varices at clinical evaluation (CEAP $2)
or venous reﬂux at the thigh or groin level, as assessed by duplex ultrasound imaging.
Results: The follow-up included 123 limbs. The combined clinical and ultrasound-determined recurrence rate was 24.4%
(30 of 123): 32.2% (20 of 62) in group A vs 16.4% (10 of 61) in group B (P[ .045). Postoperatively, recurrence of even
minimal varices was observed in 24 limbs (19.5%): 18 of 62 (29.0%) in group A vs six of 61 (9.8%) in group B (P[ .014).
The ultrasound-detected recurrence rate was 22% (27 of 123): 32.2% (20 of 62) in group A vs 11.4% (7 of 61) in group B
(P [ .010). The average time to recurrence was 3.5 ± 1.2 years in group A and 4.1 ± 1.6 years in group B (P [ .258).
Conclusions: GSV surgery without high ligation of the SFJ is associated with low rates of clinical and ultrasound-
determined recurrence of varicose veins. (J Vasc Surg 2013;58:173-8.)Previous theories1,2 assuming that primary venous without high ligation of the SFJ is beneﬁcial in terms of
reﬂux was due to the absence or incompetence of valves
above the saphenofemoral junction (SFJ) have now been
soundly discredited.3 Several studies reported saphenous
retrograde ﬂow also in patients with a competent SFJ or
saphenopopliteal junction,4,5 and saphenous vein varicosi-
ties, hypothetically resulting from valvular incompetence,
were observed even in the presence of competent valves.6
These ﬁndings suggest that primary venous reﬂux seems
to be a local or multifocal process in addition to or separate
from a retrograde process.3
As a consequence, during the last decade, the question
whether high ligation of the SFJ is necessary has become
one of the most debated issues. Although a number of
retrospective series reported good results with high ligation
of the SFJ,7,8 more recently, the trend is toward avoiding
SFJ ligation on the basis of new anatomic, clinical, and
hemodynamic evidence.9-11
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METHODS
Study population. The study enrolled 120 patients
from December 2000 to May 2004. Patients were
randomly allocated preoperatively to two groups under-
going GSV surgery with (group A) or without (group B)
high ligation of the SFJ. In four patients (two from each
group), both limbs were operated on by a staged proce-
dure. Thus, the ﬁnal study cohort included 60 patients
and 62 limbs in each group.
A previous retrospective database was used to deter-
mine the necessary sample size in each group to achieve
80% power at an a ¼ .05. The primary end point was vari-
cose vein recurrence deﬁned as minimal thigh varices at
clinical evaluation or venous reﬂux, even of mild degree
at the thigh or groin level, as assessed by duplex ultrasound
(DUS) imaging, or both. A sample size of 57 patients
per group was estimated to detect a 15% difference in
the primary outcome. Randomization was performed
by a computer-generated random-numbers algorithm.
Informed consent was obtained from all patients during
the preoperative interview. Inclusion criteria were primary
varicose veins with SFJ incompetence resulting in GSV
reﬂux. Exclusion criteria were age <18 years, inability to
give informed consent, associated small saphenous vein
incompetence, aneurysm of the SFJ, and prior GSV
surgery. Preoperative characteristics of the study popula-
tion are reported in Table I.
Preoperative evaluation. All patients underwent clin-
ical evaluation including assessment of symptoms (pain,173
Table I. Preoperative characteristics of the study patients
Variablea
Group A Group B
P(n ¼ 60) (n ¼ 60)
Age, years 45 6 14 47 6 15 .452
Sex
Male 12 (20) 15 (25)
Female 48 (80) 45 (75) .662
Body mass index, kg/m2 24.5 6 0.70 24.7 6 0.50 .142
Bilateral surgery 2 (3.3) 2 (3.3) .609
Limbs 62 62
Asymptomatic limbs 21 (34) 20 (32) .966
Venous disability score 1.41 6 0.09 1.39 6 0.06 .148
CEAP classiﬁcation .837
C2-C3 47 (76) 45 (73)
C4-C6 15 (24) 17 (27)
aContinuous data are presented as mean 6 standard deviation and categoric
data as count (percentage).
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lessness, tingling, heat), regardless of their location on
the limb. Venous clinical severity was graded according
to the venous disability score (0, symptomatic; 1, symp-
tomatic but able to perform usual activities without
compressive therapy; 2, able to perform usual activities
only with compression or limb elevation, or both; 3, unable
to perform usual activities even with compression or limb
elevation, or both).
Anatomic and hemodynamic data were obtained by
means of DUS imaging (Esaote AV4, Esaote Group,
Genoa, Italy) performed by the same operator (P.C.)
with the patient standing. Venous reﬂux of the great and
small saphenous veins was assessed using the manual
venous ﬂushing maneuver in the calf region and recorded
at the time of the sudden release of manual compression.
A reﬂux duration >0.5 second for the superﬁcial veins
and 1 second for the deep veins was considered pathologic.
Photographs were taken of all patients before and after
surgery and at each follow-up visit, to detect the develop-
ment of new varicose veins, even of very small caliber.
Terminal valve competence at the groin level was assessed
by performing a Valsalva maneuver.
Surgical procedure. Surgery was performed under
tumescent local anesthesia and continuous femoral block
and Kleine tumescence, comprising 2% lidocaine (20 mL),
1:1000 adrenaline (1 mL), and 8.4% sodium bicarbonate
(5 mL) mixed with 500 mL lactated Ringer’s solution. All
operations were performed by a single expert surgeon
(P.C.).
Group A patients underwent standard GSV surgery,
including high ligation of the SFJ, foramen ovale plasty
and infolding suture to hide the free endothelium of the
saphenous stump.
Group B patients underwent GSV surgery without
high ligation of the SFJ. After the GSV was hooked
through a small incision at lower leg level, a stripper device
was inserted. Invagination stripping was performed without
echographic guidance. The GSV was hooked at the thighlevel, 2 to 3 cm below the groin (SFJ), and GSV ligature
was performed in distal to epigastric and perineal veins to
preserve physiologic drainage.
Associated phlebectomy was performed in all patients.
In the four patients who underwent operations on both
legs, a staged procedure was preferred.
Follow-up and end points. Clinical evaluation and
DUS scanning were performed at 6 months and yearly
thereafter. The follow-up of the last operated-on patient
ended in May 2012, so that all the patients had a minimal
follow-up of 8 years. Follow-up was complete in all but one
patient (99.2%). At each follow-up visit, patients under-
went DUS examination of both lower limbs. The primary
end point was varicose vein recurrence, deﬁned as an
operated-on limb with new minimal thigh varices at clinical
evaluation (CEAP $2) or venous reﬂux at the thigh or
groin level, as assessed by DUS, or both. New varicose or
missed veins as well as stump evolution were evaluated
using DUS scanning. Stump evolution was classiﬁed into
four types: S1, thrombosis and ﬁbrosis; S2, low turbulence
during Valsalva maneuver and deﬂection at rest; S3, ﬂow
turbulence with venous reﬂux at rest; and S4, preserved
drainage function and competent terminal valve. S1, S2,
and S4 types were considered as a favorable evolution,
whereas S3 was considered to deﬁne varices recurrence.
Statistical analysis. Categoric data are reported as
counts and percentages. Normality of continuous data
was assessed by Kolmogorov-Smirnov test. Continuous
data are expressed as mean 6 standard deviation. For
comparisons of continuous and categoric variables, the
Mann-Whitney U test, c2, or the Fisher exact test was
used, as appropriate. Kaplan-Meier curves were used to
compare long-term results of the two surgical approaches.
Comparisons were made using log-rank test. The signiﬁ-
cance level was set at P < .05. Statistical analysis was per-
formed using SPSS software (SPSS Inc, Chicago, Ill).RESULTS
A total of 123 limbs were followed up 8 years after
surgery. The combined clinical and DUS-determined
recurrence rate was 24.4% (30 of 123), consisting of
32.2% (20 of 62) in group A vs 16.4% (10 of 61) in group
B (P ¼ .045; Fig 1). Postoperative recurrence of even
minimal varices was observed in 24 limbs (19.5%), consist-
ing of 18 of 62 (29.0%) in group A vs six of 61 (9.8%) in
group B ( P ¼ .014; Fig 1). The DUS-detected recurrence
rate was 22% (27 of 123), consisting of 32.2% (20/62) in
group A vs 11.4% (7/61) in group B (P ¼ .010; Fig 1).
The average time to recurrence was 3.5 6 1.2 years in
group A and 4.1 6 1.6 years in group B (P ¼ .258). In
Table II, our results are compared with results reported
in the literature.
Long-term actuarial freedom from varicose vein recur-
rence was signiﬁcantly higher in group B (85% 6 5%) than
in group A (67 6 5%, P ¼ .045; Fig 2).
Ultrasound-guided foam sclerotherapy (UGFS) was
used to treat the 30 limbs with recurrence, with the
JOURNAL OF VASCULAR SURGERY
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where a needle-hook-assisted phlebectomy was preferred.Fig 1. Cumulative, clinical, and duplex ultrasound (DUS) recur-
rence rates are shown in group A and group B patients. *P <.05.DISCUSSION
Traditional surgical treatment of varicose disease
requires highly invasive procedures, resulting in high
recurrence rates, especially in the long term.12 To over-
come these drawbacks, new endovascular techniques have
been developed, such as endovenous laser ablation
(EVLA),9,10,23-25 radiofrequency ablation (RFA),15-17 and
UGFS.13,26
Although these techniques are less invasive and associ-
ated with lower recurrence rates (Table II),11-22 high liga-
tion of the SFJ is still largely performed. A prospective
analysis in the United Kingdom showed that in 2007 to
2008, conventional surgery was performed by 96% of
public centers and by 89% of private centers. In addition,
when asked to consider future practice, 70% of surgeons
felt that conventional surgery would remain the most
common treatment modality.27 This is mainly due to extra
costs of endovenous methods (£1250 for EVLA and £1600
for RFA) compared with conventional surgery (£933).26
To reduce costs and recurrence rates, a new minimally
invasive approach has been proposed.11,28 Pittaluga et al11
demonstrated that preservation of the SFJ during GSV
stripping using a limited inguinal approach is associated
with good results in hemodynamic efﬁcacy and SFJ neovas-
cularization at 2-year follow-up (1.8%), with a clinical
recurrence rate of 6.3%. However, given the retrospective
nature of this study, no comparison with a control group
undergoing conventional surgery could be performed. In
addition, only 57.4% of the lower limbs were followed up
after the ﬁrst postoperative year. In our study, the
ultrasound-determined recurrence rate at the 2-year
follow-up was quite similar, but the clinical recurrence
rate was nearly one-half lower (3.3%).
Surgery with vs without high ligation of the SFJ.
Our minimally invasive surgical approach was associated
with a lower rate of treatment failure at short-term and
long-term follow-up compared with conventional surgery.
The freedom from recurrence curves in our series starts to
diverge at 3 years, reaching signiﬁcance at 5 years. Several
authors reported short-term recurrence rates of 4.8% to
24%,13-15 signiﬁcantly higher than the 3.3% observed in our
series. At 5 years postoperatively, surgery without high
ligation of the SFJ resulted in a recurrence rate of 9.8%,
which is signiﬁcantly lower than the 25% to 47.1% reported
for conventional surgery.12,29 A recent randomized
trial comparing different surgical treatment strategies13
observed rates of varicose vein recurrence at 1-year
follow-up of 11.6% for EVLA, 7.3% for RFA, 13.8% for
UGFS, and 14.8% for conventional surgery, which were
not signiﬁcantly different (P ¼ .155), lending support to
the hypothesis that SFJ ligation does not prevent the
development of new varices. Hence, our ﬁndings raise the
pathophysiologic question of the possible mechanisms
underlying the superiority of minimally invasive surgery.Traditionally, varicose disease has been considered to
arise from incompetence of the junction (perforator vein,
SFJ, or saphenopopliteal junction) of the superﬁcial (saphe-
nous vein) and deep venous systems (femoral and popliteal
veins). This causes blood from deep veins to ﬂow in
a reverse ﬂow pattern into the superﬁcial main veins of
the leg, leading to the development of varices.1,2 However,
Pittaluga et al11 suggested that varicose disease may
progressively extend in an antegrade fashion rather than
showing a traditional retrograde hemodynamic evolution,
endorsing the theory that venous incompetence spreads
from the superﬁcial distal venous network toward the
deep venous system. This hypothesis provided new insights
into the mechanisms responsible for the development of
recurrent varices after radical high ligation of the SFJ. In
addition, these authors also supported the idea that pre-
servation of the SFJ during GSV reﬂux treatment enables
preservation of some normal, competent tributaries
(epigastric and perineal vein draining the residual stump).11
Further, avoidance of high ligation of the SFJ may be
preferable to conventional surgery because it is less invasive
and is associated with a reduced risk of inﬂammatory reac-
tions at the site of groin dissection, resulting in a lower
grade of neovascularization. Glass30 was among the ﬁrst
to advocate that neovascularization plays a crucial role in
recurrence of varices. A later study by De Maeseneer
et al31 documented neovascularization at the site of saphe-
nous ligation in 68% of limbs with clinically detectable
recurrent varicose veins. Lefebvre-Vilardebo32 also showed
that lymph nodes in the neighborhood of the ligated
saphenous stump might actually contribute to the recur-
rence of disease. The presence of tiny veins (1-4 mm)
passing through the surrounding lymph nodes was
detected at a postoperative DUS examination of the groin,
suggesting a role of lymph nodes in the neovascularization
process. These observations indicate that when high liga-
tion is performed, a more invasive treatment via groin
access may act as an inﬂammatory trigger for neovasculari-
zation and subsequent high recurrence rates. In our
Table II. Recurrence rate assessed by Doppler ultrasound imaging: our results and review of the literature
Surgical technique No. of limbs
Follow-up, %
1 year 2 years 3 years 4 years 5 years >5 years
Conventional surgery
Our series 62 1.6 4.8 17.7 25.8 30.6 32.2 (8 years)
Kostas12 113 25
Rasmussen13 108 4.8
Pronk14 68 9.0
Theivacumar15 60 24.0
S/WL
Our series 61 3.3 3.3 4.9 6.6 9.8 11.9 (8 years)
Pittaluga11 195 2.7
EVLA
Rasmussen13 121 5.8
Pronk14 62 9.0
Theivacumar15 69 7
Min16 499 7
Ravi17 126 14 (6.7 years)
Agus18 1076 3
Disselhoff19
With ligation 30 35
Without ligation 30 21
RFA
Pichot20 63 11.1
Rasmussen13 124 4.8
Merchant21 1078 21.4
UGFS
Rasmussen13 123 16.3
Belcaro22 211 44 51 (10 years)
EVLA, Endovenous laser ablation; RFA, radiofrequency ablation; S/WL, great saphenous vein stripping without high ligation of the saphenofemoral junction;
UGFS, ultrasound-guided foam sclerotherapy.
Fig 2. Actuarial freedom from recurrence is shown in group A
(dashed line) and group B (solid line) patients. Standard errors
(range bars) are plotted.
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below the groin, preventing the proinﬂammatory stimulus
of surgical groin access.
Surgery without high ligation vs endovenous
techniques. Most studies that evaluated the safety and efﬁ-
cacy of endovenous techniques reported good short-term
and medium-term results, as assessed by DUS imaging.
In our study population, the 1-year recurrence rate of 3.3%
was lower than that achieved with EVLA (5.8%-9%),13,14RFA (4.8%),13 or UGFS (16.3%).13 This difference was
even more notable at the 4-year and 5-year follow-up
(6.6% and 9.8% in our series vs w20% in other
reports).19,21 After 5 years, the DUS recurrence rate in our
series was 11.9% vs 14% with EVLA27 and 51% with
UGFS.27 The clinical recurrence rate was even higher with
RFA (from 22.8% to 27.4%)26,33 or with EVLA (from
12.5% to 15%).16,34
Other advantages of GSV surgery without high ligation
include lower costs of the procedure and earlier return to
work as in our experience (median 2.5 days with a total
approximate cost of V1500). In a comparative randomized
trial, time to resume work ranged from 2.9 days (for UGFS
and RFA) to 3.6 days (for EVLA) with total costs,
including indirect costs of time lost from work, being
similar among the different approaches (V2199 for
conventional surgery, V2200 for EVLA, V1996 for RFA,
and V1554 for UGFS).13
In addition, endovenous procedures have several other
disadvantages comparedwith ourminimally invasive surgical
approach: (1) in the immediate postoperative period, EVLA
may induce signiﬁcant pain, whereas none of our patients
experienced postoperative pain; (2) RFA and UGFS were
associated with high rates of postoperative phlebitis (9.6%
and 13.7%, respectively)13; and (3) individuals with tortuous
or thrombosed varicose veins are usually unsuitable for
endovenous treatment, especially with increasing age.35
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acknowledged. The ultrasonographer and providerwho per-
formed the follow-up examinations were not blinded to
treatment assignment. In addition, this study aimed at
comparing surgery with vs without high ligation of the SFJ
but did not provide a direct comparison between minimally
invasive GSV surgery without high ligation of the SFJ and
other minimally invasive surgical approaches such as EVLA
and RFA.
CONCLUSIONS
Minimally invasive surgery consisting of GSV stripping
without SFJ ligation is associated with low clinical and
DUS-determined recurrence rates because it allows preser-
vation of normal, competent tributaries draining the
abdominal wall. The challenge for the future is the devel-
opment of less invasive surgical approaches leading to the
implementation of saphenous vein-sparing techniques for
incompetent GSVs.
We acknowledge Dr Michele Di Mauro for assistance
with the statistical analysis.
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